Zerrin Cantürk

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Multiple Myeloma

Endothelial Cells

Top Venues

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Archiv der Pharmazie

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Selin Engür-Öztürk, Elif Kaya-Tİlkİ, Zerrin Cantürk, Miriş Dikmen
Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 132 (8) (2024)
Selin Engür-Öztürk, Elif Kaya-Tİlkİ, Zerrin Cantürk, Miriş Dikmen
Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib'. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (2024)
Mehlika Dilek Altintop, Malihe Moradzadeh, Cüneyt Türkeş, Remzi B Öztürk, Zerrin Cantürk, Sukru Beydemir, Ahmet Özdemir
A new series of hydrazones as small-molecule aldose reductase inhibitors. Archiv der Pharmazie (2023)
Mehlika Dilek Altintop, Zerrin Cantürk, Ahmet Özdemir
Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents. ACS omega 8 (45) (2023)
Belgin Sever, Hasan Soybir, Şennur Görgülü, Zerrin Cantürk, Mehlika Dilek Altintop
Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects. Molecules (Basel, Switzerland) 25 (21) (2020)